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Homologous recombination (HR) provides an efficientmech-
anism for error-free repair of DNA double-strand breaks
(DSBs). However, HR can be also harmful as inappropriate or
untimely HR events can give rise to lethal recombination inter-
mediates and chromosome rearrangements. A critical step of
HR is the formation of a RAD51 filament on single-stranded
(ss)DNA, which mediates the invasion of a homologous DNA
molecule. Inmammalian cells, several DNA helicases have been
implicated in the regulation of this process. RECQ5, a member
of the RecQ family of DNA helicases, interacts physically with
the RAD51 recombinase and disrupts RAD51 presynaptic fila-
ments in a reactiondependent onATPhydrolysis.Here,wehave
preciselymapped theRAD51-interactingdomainofRECQ5and
generated mutants that fail to interact with RAD51. We show
that although thesemutants retain normalATPase activity, they
are impaired in their ability to displace RAD51 from ssDNA.
Moreover, we show that ablation of RECQ5-RAD51 complex
formation by a point mutation alleviates the inhibitory effect of
RECQ5 on HR-mediated DSB repair. These findings provide
support for the proposal that interaction with RAD51 is critical
for the anti-recombinase attribute of RECQ5.
Homologous recombination (HR)2 provides an efficient
mechanism for accurate repair of DNA double-strand breaks
(DSBs) that are generated during S/G2 byDNA-damaging agents
or arise as a consequence of replication fork demise (1, 2). How-
ever,HRmust be tightly regulated, as it could generate toxic inter-
mediates, interferewith other importantDNArepair pathways, or
give rise to gross chromosomal rearrangements (3, 4).
In the budding yeast Saccharomyces cerevisiae, the Srs2DNA
helicase regulates HR at an early step by acting as a DNA
translocase that disassembles the Rad51 presynaptic fila-
ment, which catalyzes the invasion of the donor chromatid
to give rise to a three-stranded structure called a displace-
ment (D)-loop (5, 6). In mammalian cells, several DNA heli-
cases have been implicated in the regulation of HR initiation
(7–10). One of these, RECQ5, belongs to the RecQ family of
DNA helicases that play important roles in maintenance of
genomic stability (11). Inactivation of the Recql5 gene in
mice results in genomic instability and cancer susceptibility
(8). Cells derived from the knock-out mice show increased
frequency of sister chromatid exchanges and chromosomal
rearrangements, prolonged persistence of RAD51 foci after
replication stress and elevated efficiency of HR-mediated
DSB repair as compared with normal cells, suggesting that
RECQ5 acts as a suppressor of HR (7, 8). Human RECQ5 has
been shown to accumulate at sites of DNA DSBs and repli-
cation arrest in a manner dependent on the MRE11-RAD50-
NBS1 complex, a key player in DNA damage recognition and
repair (12). Like Srs2, RECQ5 physically interacts with
RAD51 and possesses the ability to disrupt ATP-bound form
of RAD51-ssDNA filament, thereby preventing RAD51-me-
diated D-loop formation (8).
The mechanism of how RECQ5 removes RAD51 from
ssDNA is not completely understood. RECQ5-mediated release
of RAD51 from ssDNA is fully dependent on the ATPase activ-
ity of RECQ5 that drives its translocation alongDNA (8).More-
over, this reaction is enhanced by the ssDNA-binding factor
replication protein A (RPA) that prevents renucleation of
RAD51 onto DNA (8). Interestingly, other RecQ helicases such
as WRN are not capable of catalyzing RAD51 presynaptic fila-
ment disruption, suggesting that RECQ5-mediated removal of
RAD51 from ssDNA does not stem simply from its ssDNA
translocase activity (8).
Here we address the role of the physical interaction between
RECQ5 andRAD51 in the anti-recombinase activity of RECQ5.
We have precisely mapped the RAD51-interacting domain of
RECQ5 and generated mutants that retain normal ATPase
activity, but fail to interact with RAD51. Using these mutants,
we show that loss of interaction between RECQ5 and RAD51
significantly reduces the anti-recombinase activity of RECQ5
both in vitro and in vivo. These data support the proposal that
RECQ5 regulates HR by disrupting RAD51 presynaptic
filaments.
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EXPERIMENTAL PROCEDURES
Plasmid Constructs and Protein Purification—Plasmid con-
structs for bacterial production of human RECQ5 and its vari-
ants are derived from the pTXB1 vector, in which protein of
interest is expressed as a C-terminal fusion with a self-cleaving
affinity tag composed of a Mxe intein fragment and a chitin-
binding domain (CBD) (New England Biolabs). The plasmids
pPG10 (wild-type RECQ5; amino acids 1–991), pPG17
(RECQ51–410), pPG19 (RECQ51–475), pPG21 (RECQ51–561),
pPG20 (RECQ51–651), pPG18 (RECQ51–725), pPG11
(RECQ5675–991), and pPG16 (RECQ5411–991) were described
previously (13, 14). Note that the numbers in superscript refer
to RECQ5 codons. The expression vector for RECQ5529–725
(pPG10N529–725C) was constructed by PCR amplification of
the corresponding part of the RECQ5 cDNA followed by its
cloning in pTXB1 via NdeI/SapI sites. The internal deletion
variant of RECQ5, RECQ5640–653, was constructed by linking
two PCR products via Acc65I site that is in-frame with the
codons 639 and 654 of RECQ5. The PCR products were cleaved
with SacI/Acc651 (N-terminal fragment) and Acc65I/Bsu36I
(C-terminal fragment), respectively, and ligated with the
Bsu36I/SacI fragment of pPG10. Note that the resulting con-
struct (pPG10640–653) contains two additional codons
(GGTACC; Acc65I site) in between the codons 639 and 654.
The expression vectors for RECQ5652–674 (pPG10652–674)
and RECQ5652–725 (pPG10652–725) were constructed using
the same strategy. The expression vectors for RECQ5515–568
(pPG10515–568), RECQ5543–607 (pPG10543–607) and
RECQ5571–653 (pPG10571–653) were constructed using
restriction enzymes. The pPG10515–568 plasmid results
from FspI/BsaAI deletion of pPG10. The pPG10543–607
plasmid results from BamHI/EcoRV deletion of pPG10 where
BamHI end was filled by Klenow fragment. The pPG10571–
653 plasmid results from BsaAI/Acc65I deletion of
pPG10640–653 where the Acc65I end was filled by Klenow
fragment. The expression vectors for RECQ5R654A
(pPG10R654A), RECQ5F659A (pPG10F659A), RECQ5F666A
(pPG10F666A), and RECQ5E671A (pPG10E671A) were pre-
pared using QuikChange site-directed mutagenesis kit (Strat-
agene) with pPG10 as template. For ectopic expression of
RECQ5, RECQ5652–674, and RECQ5F666A in human cells, the
pcDNA3.1/HisC vector (Invitrogen) was used. For wild-type
RECQ5, RECQ5 cDNA was cloned between BamHI and NdeI
sites in pcDNA3.1/HisC. The BamHI end of the cleaved vector
was filled in by Klenow fragment. In the resulting plasmid,
named pJP136, the N terminus of RECQ5 is fused to a (His)6-
Xpress epitope tag. The expression vector for RECQ5652–674
(pJP136652–674) was generated by replacement of the
BstEII-Bsu36I fragment in pJP136 with the BstEII-Bsu36I frag-
ment of pPG10652–674. The expression vector for
RECQ5F666A was constructed using the same strategy with
pPG10F666A as a source of the F666A mutation.
Wild-type and mutant forms of human RECQ5 were pro-
duced and purified as described previously (13, 14). Human
RAD51K133R, RPA, Hop2-Mnd1, and Escherichia coli DNA
topoisomerase I were purified according to previously pub-
lished protocols (15–18). Wheat germ DNA topoisomerase I
was purchased from Promega. SDS-PAGE analysis of the puri-
fied proteins used in this study is shown in supplemental Fig. S1.
CBD Pull-down Assay—RECQ5 and its variants were pro-
duced as C-terminal fusions with CBD tag in E. coli BL21-
CodonPlus(DE3)-RIL (Stratagene). Cellswere grown at 37 °C in
LB medium containing 150 g/ml ampicillin and 25 g/ml
chloramphenicol. At an A600 of 0.3, protein synthesis was
induced by adding isopropyl-1-thio--D-galactopyranoside to a
concentration of 0.2 mM, and cultures were incubated over-
night at 18 °C. Cells harvested from a 10-ml culture were resus-
pended in 1 ml of buffer CH (20 mM Tris-HCl (pH 8), 500 mM
NaCl, 1 mM EDTA, 0.1% (v/v) Triton X-100) supplemented
with 0.2mMPMSF and a protease inhibitormixture (Complete,
EDTA-free; Roche). Cells were disrupted by sonication and the
resulting extracts were clarified by centrifugation at 20,000 g
for 45 min at 4 °C. Cleared extracts (typically 50 l) were incu-
batedwith 25l of chitin beads (NewEnglandBiolabs) in a total
volume of 500 l of buffer CH supplemented with 0.2 mM
PMSF and protease inhibitor mixture for 2 h at 4 °C. The beads
were then washed once with 1 ml of CH buffer and three times
with 1 ml of buffer TN1 (50 mM Tris-HCl, pH 8, 120 mM NaCl,
0.5% (v/v)Nonidet P-40). After eachwash, beadswere collected
by centrifugation at 3,000  g for 2 min at 4 °C. The washed
beads were incubated for 2 h at 4 °C with total extract from
human embryonic kidney cells HEK293T (600g of protein) in
a volume of 500 l of buffer TN1 supplemented with 0.2 mM
PMSF and protease inhibitor mixture, and then washed again
three times with buffer TN1. Bound proteins were released
from the beads by adding 25 l of 3 SDS-loading buffer fol-
lowed by incubation at 95 °C for 7 min. Eluted proteins were
separated by 10% SDS-PAGE and analyzed byWestern blotting
using rabbit polyclonal anti-RAD51 antibody (BD Pharmingen,
Cat. No. 551922; 1:5,000 dilution).
Ni-NTA Pull-down Assay—HEK293T cells grown in Dul-
becco modified Eagle’s medium (DMEM) (Invitrogen) supple-
mented with 5% fetal calf serum (Invitrogen), streptomycin/
penicillin (100 units/ml) were transfected with the expression
vectors for RECQ5, RECQ5652–674, RECQ5F666A or with the
corresponding empty vector (pcDNA3.1/HisC). One day
before transfection, 1 106 cells were seeded in 10-cm plates.
Next day, 2 g of appropriate vector were mixed with 7 l of
Metafectene reagent (Biontex) suspended in 100 l of DMEM.
This mixture was incubated at room temperature for 20 min
and subsequently added to cells at about 40% confluency. 48 h
post-transfection, plates were placed on ice and washed twice
with 8 ml of ice-cold phosphate-buffered saline followed by
addition of 500 l of extraction buffer TN2 (50 mM Tris-HCl,
pH8, 120mMNaCl, 20mMNaF, 15mM sodiumpyrophosphate,
0.5% (v/v) Nonidet P-40) supplemented with 1 mM benzami-
dine, 0.2 mM PMSF, 0.5 mM sodium orthovanadate and prote-
ase inhibitor mixture (Roche). Cell suspension was gently
scraped off the plate, snap frozen in liquid nitrogen, thawed and
centrifuged at 20,000  g for 30 min at 4 °C. Clarified extract
(typically 800 g of protein) was incubated with 25 l of Ni-
NTA-Agarose beads (Qiagen) for 2 h at 4 °C in a volume of 500
l of extraction buffer TN2 supplemented with protease/phos-
phatase inhibitors as above and 20 mM imidazole. Where
required, extracts were pretreated with 20 units of DNaseI
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(Roche) for 20 min at 25 °C in the presence of 6 mMMgCl2 and
1 mM CaCl2. After incubation, the beads were washed three
times with 1ml of buffer TN2 supplementedwith PMSF and 20
mM imidazole. After eachwashing step, beadswere collected by
centrifugation at 3,000  g for 2 min at 4 °C. Bound proteins
were released from nickel beads by adding 25 l of 3 SDS-
loading buffer followed by incubation at 95 °C for 7min. Eluted
proteins were separated by 10% SDS-PAGE and analyzed by
Western blotting. Membranes were probed with rabbit poly-
clonal anti-RAD51 antibody (BDPharmingen, Cat. No. 551922;
1:5,000 dilution) and goat polyclonal Omni-probe antibody
(Santa Cruz Biotechnology, sc-499-G; 1:1,000 dilution). The
latter antibody is raised against the (His)6-Xpress tag.
DNA Substrates—Oligonucleotide D1 complementary to
positions 1932–2022 of the pBluescript replicative form I DNA
(5) was 5-end-labeled with T4 polynucleotide kinase and
[-32P]ATP (PerkinElmer). Bacteriophage M13mp8.32 ssDNA
was produced in E. coli JM109 and isolated according to stand-
ard protocol (19). To generate topologically relaxed dsDNA
plasmid, typically 4 g of supercoiled pGEM-7Zf() DNA
(Promega) were incubated with 1.6 g of E. coli DNA topo-
isomerase I at 37 °C for 30 min in 40 l of buffer R (25 mM
Tris-HCl, pH 7.5, 1mMMgCl2, 50mMKCl, 1mMdithiothreitol,
100 g/ml bovine serum albumin), followed by heat inactiva-
tion of the enzyme at 65 °C for 10 min.
D-loop Reaction—Reactions were carried out at 37 °C in
buffer R (see above; KCl present at a concentration of 80 mM)
containing an ATP-regenerating system consisting of 20 mM
creatine phosphate (Sigma), 20 g/ml creatine kinase (Sigma)
and 2 mM ATP. RAD51K133R (1 M) was incubated with the
5-end labeled 90-mer oligonucleotideD1 (3Mnucleotides) in
11 l of buffer R for 5 min, followed by the incorporation of
Hop2-Mnd1 (300 nM) in a volume of 0.75 l and a 1-min incu-
bation. The reaction was initiated by adding pBluescript repli-
cative form IDNA (50Mbase pairs) in a volumeof 0.75l. The
reactions were terminated after 6 min by the addition of 0.8 l
each of 10% SDS and proteinase K (10 mg/ml). Following a
3-min incubation, the reaction mixtures were resolved in 0.9%
agarose gels run in 1TAE buffer (40mMTris acetate (pH 7.4),
0.5 mM EDTA). The gels were dried and subjected to phosphor-
imaging analysis. When present, RPA (135 nM) and RECQ5 or
its mutants (15–30 nM) were added to the preassembled
RAD51K133R filaments, followed by a 4-min incubation before
the incorporation of Hop2-Mnd1 and replicative form I DNA.
Topoisomerase I-linked DNA Topology Modification Assay—
Reactionswere carried out at 37 °C in an end-volume of 25l of
buffer R containing an ATP-regenerating system consisting of
10 units/ml creatine kinase, 12 mM creatine phosphate, and 2
mMATP.Typically, 375 nMRAD51K133Rwas preincubatedwith
circular M13mp8.32 ssDNA (9 M nucleotides) for 6 min, fol-
lowedby addition of the indicated concentrations of RECQ5 (or
its mutants) and 150 nM RPA. After a 6-min incubation, topo-
logically relaxed pGEM-7Zf() DNA (7 M base pairs) and
wheat germ DNA topoisomerase I (3 units) were added, and
incubation continued for a further 8 min. Reactions were
stopped by the addition of 5 l of solution S2 (6% (w/v) SDS,
0.1 M EDTA, and 10 mg/ml proteinase K) followed by a 25-min
incubation at 37 °C. DNA products were resolved by electro-
phoresis in 1% agarose gel run in 0.5 TBE buffer at 100 V for
2 h. Gels were stained in ethidium bromide solution (0.5
g/ml), and DNA species were visualized using a UV
transilluminator.
DSB Repair Assay—Generation of the DR-GFP HEK293 cell
line was described previously, along with culture conditions
(20). To measure HR, 2  105 cells were plated in a 12-well
plate, and transfected the next day with various plasmidsmixed
with 3.6l of Lipofectamine 2000 (Invitrogen) in a 1-ml culture
medium without antibiotics. Transfections included 0.8 g of
I-SceI expression vector (pCBASce) and either 0.4 g or 0.8 g
of a second plasmid: empty vector (pcDNA3.1/HisC), an
expression vector for RECQ5 (pJP136), or an expression vector
for RECQ5F666A (pJP136F666A). Four hours after transfection,
the medium was changed, and 3 days after transfection, the
percentage of GFP cells from each transfection were quanti-
fied on a Cyan ADP (Dako).
RESULTS
Mapping of the RAD51-interacting Domain in RECQ5—To
map the RAD51-interaction site on RECQ5, we performed a
RAD51 pull-down assay with a series of N- and C-terminal
truncation variants of RECQ5 that were produced in bacteria as
fusions with CBD (Fig. 1A). Recombinant proteins were bound
to chitin beads via the CBD tag and subsequently incubated
with HEK293T cell extract. RAD51 binding to RECQ5-coated
beads was analyzed by Western blotting. The obtained data
indicated that the RAD51-interacting domain of RECQ5 is
located between amino acids 411 and 725 (Fig. 1B). Tomap the
location of this domainmore precisely, we generated a series of
internal deletions within the region of RECQ5 spanning amino
acids 515–725 (Fig. 1A). These RECQ5 mutants were again
tested for their ability to bindRAD51 in aCBDpull-down assay.
This experiment indicated that the region of RECQ5 spanning
amino acids 515–653 was dispensable for RAD51 binding (Fig.
1C, lanes 4–7). In contrast, deletion of the amino acids 652–
674 or 652–725 of RECQ5 completely abolished its interaction
with RAD51 (Fig. 1C, lanes 8 and 9). In addition, we found that
the RECQ5 fragment comprised of amino acids 529–725 could
bind RAD51 to a similar extent as the full-length RECQ5 (Fig.
1C, compare lanes 3 and 10). Collectively, the above data indi-
cate that RECQ5 contains a single RAD51-interacting domain
that is located between amino acids 654 and 725.
Ablation of the RECQ5-RAD51Complex by a PointMutation—
In an attempt to identify amino acid residues of RECQ5 that are
critical for RAD51 binding, we generated single alanine substi-
tutions at charged and aromatic residues within the region
spanning amino acids 654–674 that was found to be required
for RECQ5-RAD51 complex formation (Fig. 1C, lane 8). The
following residues of RECQ5 were mutated: Arg-654, Phe-659,
Phe-666, and Glu-671. The mutant proteins were again
expressed in bacteria as fusions with CBD, immobilized on
chitin beads and tested for their ability to bind RAD51 from
HEK293T cell extract. We found that the alanine substitutions
at Arg-654 and Phe-659 of RECQ5 had no effect on its binding
to RAD51, while the F666A substitution abolished RAD51
binding by RECQ5 and the E671A substitution reduced it sig-
nificantly (Fig. 2A).
RAD51 Filament Disruption by RECQ5
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Next, we investigated the effect of
F666A and 652–674 mutations of
RECQ5 on RECQ5-RAD51 com-
plex formation in vivo. To this end,
HEK293T cells were transiently
transfected with expression vectors
for wild-type or mutant forms of
RECQ5 fused N-terminally to a
(His)6-Xpress tag. The ectopically
expressed RECQ5 variants were iso-
lated from cell extracts using
Ni-NTA beads and analyzed by
Western blotting to test for co-pre-
cipitation of the endogenous
RAD51 protein. We found that
RAD51 was bound to wild-type
RECQ5, but not to RECQ5652–674
orRECQ5F666A (Fig. 2B). Treatment
of cell extract with DNaseI did not
affect the binding of RAD51 to
RECQ5, indicating that the RECQ5-
RAD51 interaction is not mediated
through DNA binding (supplemen-
tal Fig. S2). Collectively, these data
indicate that phenylalanine 666 of
RECQ5 is essential for binding of RECQ5 to RAD51 in vitro and
in vivo.
Interaction of RECQ5with RAD51 Is Important for the Atten-
uation of RAD51-mediatedDNAPairing—Wepreviously dem-
onstrated that RECQ5 in the presence of RPA effectively inhib-
ited RAD51-mediated D-loop formation. We employed the
D-loop assay to compare the anti-recombinase activities of our
mutants to that of the wild-type enzyme (Fig. 3A). As in our
previous study, we used a K133R mutant of RAD51, which
binds ATP, but is greatly attenuated for ATP hydrolysis and
hence forms a highly stable filament on ssDNA that is fully
proficient in catalyzing strand invasion of a homologous DNA
molecule (21). To enhance the efficiency of theD-loop reaction,
the accessory factorHop2-Mnd1was included in the assay (22).
We first tested the activities of the C-terminal deletionmutants
of RECQ5, RECQ51–725, and RECQ51–651, of which the former
includes the intact RAD51-interacting domain whereas the lat-
ter lacks this domain (Fig. 1A). We found that the RECQ51–725
mutant inhibited theD-loop reaction to a comparable degree as
wild-type RECQ5 (Fig. 3B). In contrast, RECQ51–651 mutant
exhibited only a slight inhibitory effect on the D-loop reaction
(Fig. 3B). Likewise, RAD51 interaction defective mutants
RECQ5652–674 and RECQ5F666A, both showed decreased abil-
ity to attenuate RAD51-mediated D-loop formation (Fig. 3C).
To verify that the observed reduction of anti-recombinase
activity in RAD51 interaction-deficient mutants of RECQ5
does not result from a defect in ssDNA translocation, we com-
pared the ssDNA-stimulated ATPase activities of these
mutants with that of wild-type RECQ5.We found that all these
RECQ5 mutants displayed a level of ATPase activity compara-
ble to that of wild-type protein (supplemental Fig. S3).
Together, these results provide the first evidence that the phys-
FIGURE 1. Mapping RAD51-interacting domain of RECQ5. A, domain organization of human RECQ5 and
schemes of RECQ5 deletion variants used in this study. RQC, RecQ C-terminal domain, which contains a Zn2-
bindingmotif that is essential for the helicase activity of RECQ5; PIM, PCNA-interactingmotif. The dashed lines
indicate location of the RAD51-interacting domain. B and C, CBD pull-down assay. Indicated RECQ5 variants
were produced in E. coli as fusion with CBD and bound to chitin beads as described under “Experimental
Procedures.” Beadswere incubatedwith293T cell extract (600gofprotein), andRAD51bindingwas analyzed
byWestern blotting using anti-RAD51 antibody. Blotswere also stainedwith Ponceau S to visualize RECQ5 and
its variants.
FIGURE 2. Identification of amino acid residues of RECQ5 that are critical
for RECQ5-RAD51 complex formation. Single alanine substitutions were
created at the charged and aromatic residues in the region of RECQ5 span-
ning amino acids 654–674 that was found to be essential for interaction
with RAD51. A, CBD pull-down assay was performed with the indicated
RECQ5 mutants expressed in E. coli as fusion with CBD. Chitin beads
coated with wild-type or mutant forms of RECQ5 were incubated with
293T cell extract (600 g of protein) as described under “Experimental
Procedures.” RAD51 binding was detected byWestern blotting using anti-
RAD51 antibody (bottom panel). RECQ5 proteins were visualized by Pon-
ceau S staining (top panel). B, wild-type and mutant forms of RECQ5 were
expressed ectopically in 293T cells as N-terminal fusions with a (His)6-
Xpress epitope tag. Extracts from these cells (800 g of protein) were
incubatedwith Ni-NTA-beads and bound proteins were analyzed byWest-
ern blotting using anti-RAD51 andOmni-probe antibodies. The latter anti-
body recognizes the (His)6-Xpress tag.
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ical interaction between RECQ5 and RAD51 plays an impor-
tant role in the anti-recombinase activity of RECQ5 in vitro.
Physical Interaction between RECQ5 and RAD51 Facilitates
RECQ5-catalyzed Disruption of RAD51 Presynaptic Filament—
Next we sought to examine whether the observed impairment
of anti-recombinase activity in RAD51 interaction-deficient
mutants of RECQ5 stems from an inability to disrupt RAD51
presynaptic filaments. To monitor RAD51 displacement from
ssDNA, we employed DNA topology modification assay used
previously to characterize the presynaptic filament disruption
function of Srs2 (5). This assay is based on the observation that
binding of RAD51 to dsDNA induces lengthening of the DNA
(23, 24) that in case of topologically relaxed circular DNA, can
be monitored as a reduction in the DNA linking number upon
inclusion of eukaryotic DNA topoisomerase I in the reaction
(Fig. 4A). In these experiments, we again employed the
RAD51K133R mutant that forms stable nucleoprotein filament
on ssDNA. We found that the RECQ51–725 mutant displayed
similar RAD51K133R displacement activity as wild-type RECQ5,
indicating that the region of RECQ5
distal to the RAD51-interacting
domain plays little or no role in the
filament disruption activity of
RECQ5 (Fig. 4B, lanes 5 and 6). In
contrast, the filament disruption
activity of the RECQ51–651 mutant
that lacks the entire RAD51-inter-
acting domain was found to be sig-
nificantly reduced compared with
that of wild-type RECQ5 (Fig. 4B,
lanes 5 and 7). Similarly, the
mutants with defective RAD51-in-
teracting domain, RECQ5F666A and
RECQ5652–674, showed a signifi-
cant reduction in their abilities to
disrupt RAD51K133R-ssDNA fila-
ments as compared with wild-type
RECQ5 (Fig. 4,C andD). These data
provide direct evidence that the
physical interaction between
RECQ5 and RAD51 facilitates
RECQ5-catalyzed disruption of
RAD51 filaments.
Physical Interaction of RECQ5
with RAD51 Plays a Role in Its Anti-
recombination Activity in Vivo—Fi-
nally, we sought to investigate the
role of the physical interaction
between RECQ5 and RAD51 in the
anti-recombination activity of
RECQ5 in vivo. To this end, we
compared the ability for wild-type
RECQ5 versus the F666A mutant to
exert a trans-dominant negative
effect on HR-mediated repair of an
endonuclease-generated chromo-
somal DSB, using the DR-GFP
reporter integrated into HEK293
cells (20). In this reporter, the recognition site for the rare cut-
ting endonuclease I-SceI is integrated into a full-length GFP
gene (SceGFP) that is followed by an internal GFP fragment
(iGFP) (Fig. 5A). Repair of the I-SceI-generated DSB by HR
using the iGFP fragment as a template restores a functionalGFP
gene. Thus, the frequency of HR can be quantified as the per-
centage of GFP cells by FACS analysis. From these experi-
ments, we found that overexpression of wild-type RECQ5
caused a decrease in the frequency of HR (Fig. 5B). The F666A
mutant of RECQ5 also reduced the frequency of HR, but this
inhibitory effect was significantly lower than that of wild-type
RECQ5 (Fig. 5B). These data indicate that the suppression of
HR by RECQ5 in vivo is partially dependent on the formation of
RECQ5-RAD51 complex.
DISCUSSION
Genetic ablation of RECQ5 leads to hyper-recombination
and cancer susceptibility in mice (8). Biochemical studies have
revealed that RECQ5 interacts physically with the RAD51
FIGURE 3.Role of the RECQ5-RAD51 complex in RECQ5-mediated inhibition ofD-loop reaction.A, D-loop
reaction scheme. B and C, effect of wild-type and mutant forms of RECQ5 on RAD51-mediated D-loop forma-
tion. RAD51K133R (1 M) was incubated with a 5-end-labeled 90-mer oligonucleotide (3 M nucleotides) to
form a presynaptic filament, which was then incubated for 4 min with the indicated concentrations of wild-
type or mutant forms of RECQ5 in the presence of RPA (135 nM), followed by addition of Hop2-Mnd1 (300 nM)
andpBluescript form IDNA (50Mbase pairs). After a 6-min incubation, the reaction productswere resolved in
0.9% agarose gels and visualized by phosphorimaging (left panels). Gels were quantified using ImageQuant
software, and the concentration of D-loop products calculated as a percentage of the amount of product
generated in the standard (Std) reaction carried out in the absence of RECQ5. The average values S.E. from
three or more independent experiments are plotted (right panels). Asterisks denote statistically significant
difference as compared with full-length (FL) RECQ5 by an unpaired Student’s t test: *, p 0.05; **, p 0.005.
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recombinase and displaces RAD51 from ssDNA in a manner
dependent on ATP hydrolysis (8). Herein, we provide evidence
that efficient RAD51-ssDNA nucleoprotein filament disrup-
tion by RECQ5 is reliant on protein complex formation.
Through an extensive domain mapping effort, we show that
RECQ5 interacts with RAD51 through a 70 amino acid domain
that is located within the non-conserved C-terminal-half of the
RECQ5 protein. Abolishment of the physical interaction
between RECQ5 and RAD51 by mutations within this domain
significantly reduces the ability of RECQ5 to disrupt the ATP-
bound form of RAD51-ssDNA filament in vitro and to inhibit
HR-mediated DSB repair in vivo. These findings support the
proposal that RECQ5 suppresses HR by disrupting RAD51 pre-
synaptic filaments.
Recent studies have shown that disruption of Rad51 presyn-
aptic filaments by the S. cerevisiae Srs2 helicase is also depen-
dent on a specific protein-protein interaction between Srs2 and
Rad51 (25–27). It has beendemonstrated that binding of Srs2 to
Rad51 stimulates ATP hydrolysis within the Rad51 filament,
which causes Rad51 dissociation from the DNA (27). Based on
these observations, amodel has been proposed where the ATP-
dependent ssDNA-translocase activity of Srs2 serves to posi-
tion Srs2 for binding to each successive Rad51 subunits of the
presynaptic filament to promote its dissociation from DNA by
allosterically activating ATP hydrolysis by Rad51 (27). Because
Srs2 also stimulated ATP hydrolysis by the K191R mutant of
Rad51, an equivalent to the K133R
mutant of human RAD51 used in
our study, and promoted its dissoci-
ation from ssDNA, it is possible that
RECQ5-mediated disruption of
RAD51 presynaptic filaments
occurs via a similarmechanism (27).
However, RECQ5 mutants defec-
tive in interacting with RAD51 still
exhibited a considerable level of
RAD51 displacement activity in
DNA topology modification assay
(Fig. 4). Therefore, it is also possible
that RECQ5 disrupts presynaptic
filament by means of its ssDNA-
translocase activity in a manner
similar to the T4 Dda helicase (28),
and the interaction betweenRECQ5
and RAD51 serves to facilitate the
loading of RECQ5 on the DNA. It is
also possible that the residual activ-
ity of RECQ5 mutants stems from
RECQ5-mediated dissociation of
ADP-bound RAD51 molecules
resulting from basal ATP hydrolysis
in the presynaptic filament. How-
ever, this scenario is less likely
because we found that the
RAD51K133R-ssDNA filament was
fairly stable in the presence of the
BLM helicase3 that was shown to be
capable of disrupting the ADP-
bound form of the RAD51 filament (29).
Srs2 interacts with Rad51 through a domain that is located in
the middle of the C-terminal-half of the Srs2 polypeptide while
the N-terminal half of the Srs2 polypeptide constitutes the
DNA-translocase/helicase module (25). Notably, such a
domain organization is also seen in RECQ5 (Fig. 1A). In addi-
tion, RECQ5 and Srs2 contain a PCNA interaction domain at
their extreme C termini (14, 30, 31). Thus, RECQ5 and Srs2
exhibit extensive structural similarity that further supports the
notion that these proteins have similar roles in the regulation of
HR. However, a question arises as to how do these anti-recom-
binase distinguish between appropriate and inappropriate
RAD51 filaments? Accumulating evidence suggests that Srs2
removes Rad51 from ssDNA indiscriminately, whereas recom-
binationmediators such as Rad52 act to reform filaments when
and where they are appropriate (32). Biochemical experiments
clearly showed that Rad52 is sufficient to overcome the inhibi-
tory effect of Srs2 on Rad51-mediated D-loop reaction (32).
Interestingly, Srs2 and Rad52 interact with overlapping motifs
on Rad51, which are conserved throughout evolution (26). It
will be interesting to test whether thesemotifs contribute to the
association of RAD51 with RECQ5 and BRCA2 in human cells.
Like yeast Rad52, BRCA2 protein targets RAD51 to RPA-
3 P. Janscak, unpublished observation.
FIGURE 4. Role of RECQ5-RAD51 complex in RECQ5-catalyzed displacement of RAD51 from ssDNA.
A, scheme of DNA topology modification assay. RAD51 filaments pre-assembled on circular ssDNA are incu-
bated with RECQ5. A relaxed plasmid DNA (dsDNA) is subsequently added to this reaction to trap RAD51
molecules displaced from ssDNA. RAD51 binding to topologically relaxed dsDNA induces lengthening of the
DNA that can be monitored as a reduction in the DNA linking number upon treatment with eukaryotic DNA
topoisomerase I. PK, proteinase K. B–D, effect of wild-type and mutant forms of RECQ5 on the stability of
RAD51K133R presynaptic filament. RAD51K133R was assembled on M13 ssDNA (9 M nucleotides) in the pres-
ence of 2mMATP andATP-regenerating system, and then incubatedwithwild-type ormutant forms of RECQ5
(160 nM in B and 40, 80, and 160 nM inC andD) and RPA (150 nM) for 6min before addition of relaxedDNA (7M
bp) and wheat germ DNA topoisomerase I. Reactions were analyzed by electrophoresis in 1% agarose gel
followed by ethidium bromide staining. Gels were quantified using ImageQuant software and the concentra-
tion of supercoiled DNA products calculated as a percentage of the amount of product generated in the
reaction carried out in the absence of ssDNA, RECQ5, and RPA (lane 3). The tables under each gel show the
average values from two or more independent experiments.
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coated ssDNA and promotes assembly of the presynaptic fila-
ment (1). It has been shown that the C-terminal region of
BRCA2 binds to and stabilizes the RAD51 presynaptic filament
(33). In this regard, it will be also interesting to evaluate the
effect of this BRCA2 domain on the RAD51 filament disruption
activity of RECQ5.
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FIGURE 5. Role of physical interaction between RECQ5 and RAD51 in the
suppression of HR-mediated DSB repair in human cells. A, diagram of the
DR-GFP reporter alongwith thehomology-directed repair (HDR) product that
gives rise to GFP cells. B, effect of overexpression of wild-type (WT) RECQ5
and the F666Amutant on HR repair of an I-SceI-induced DSB in HEK293 cells.
Cells were transfected with an I-SceI expression vector along with the indi-
cated amounts of either an expression vector for RECQ5 (WT or F666A) or
empty vector (EV). Shown are the levels of repair relative to themean value of
a parallel set of EV transfections. Data represent the mean values of three
independent transfections. Error bars reflect the S.D. Asterisks denote statisti-
cally significant difference as compared with WT RECQ5 by unpaired Stu-
dent’s t test (p  0.0086 for 0.4 g of plasmid DNA; p  0.006 for 0.8 g of
plasmid DNA).
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